Literature DB >> 9699651

PTEN mutations and microsatellite instability in complex atypical hyperplasia, a precursor lesion to uterine endometrioid carcinoma.

R L Levine1, C B Cargile, M S Blazes, B van Rees, R J Kurman, L H Ellenson.   

Abstract

The two most common types of genetic alterations yet identified in uterine endometrioid carcinoma (UEC) are PTEN mutations and microsatellite instability (MI). Furthermore, MI-positive UECs (defined as tumors with detectable alterations at two or more different microsatellite loci) are significantly more likely to contain PTEN mutations than are MI-negative UECs. To determine whether PTEN inactivation is a relatively early event in endometrial tumorigenesis, we evaluated complex atypical hyperplasia (CAH), the direct precursor to UEC, for the presence of PTEN mutations. Mutations were present in 3 of 11 (27%) CAHs with synchronous UEC and in 4 of 18 (22%) CAHs that were not associated with invasive carcinoma. One case with synchronous CAH and UEC contained a germ-line PTEN mutation. In addition, we evaluated the same series of CAHs for MI. We identified four MI-positive CAHs with synchronous UEC but did not detect the MI phenotype in any CAHs without associated invasive carcinoma. A PTEN-mutant (germ-line mutation) MI-negative CAH was synchronous with a PTEN-mutant MI-positive UEC. These results suggest that mutation of PTEN can be an early event in the pathogenesis of UEC and may precede the development of the MI phenotype in a subset of cases.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9699651

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  58 in total

Review 1.  Modern trends into the epidemiology and screening of ovarian cancer. Genetic substrate of the sporadic form.

Authors:  Maria Koutsaki; Apostolos Zaravinos; Demetrios A Spandidos
Journal:  Pathol Oncol Res       Date:  2011-12-09       Impact factor: 3.201

2.  Mutation and expression analyses reveal differential subcellular compartmentalization of PTEN in endocrine pancreatic tumors compared to normal islet cells.

Authors:  A Perren; P Komminoth; P Saremaslani; C Matter; S Feurer; J A Lees; P U Heitz; C Eng
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

3.  PTEN expression causes feedback upregulation of insulin receptor substrate 2.

Authors:  L Simpson; J Li; D Liaw; I Hennessy; J Oliner; F Christians; R Parsons
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

4.  A novel three-dimensional culture system of polarized epithelial cells to study endometrial carcinogenesis.

Authors:  Núria Eritja; David Llobet; Mónica Domingo; Maria Santacana; Andree Yeramian; Xavier Matias-Guiu; Xavi Dolcet
Journal:  Am J Pathol       Date:  2010-04-15       Impact factor: 4.307

5.  Tumor genetic analyses of patients with metastatic melanoma treated with the BRAF inhibitor dabrafenib (GSK2118436).

Authors:  Katherine L Nathanson; Anne-Marie Martin; Bradley Wubbenhorst; Joel Greshock; Richard Letrero; Kurt D'Andrea; Steven O'Day; Jeffrey R Infante; Gerald S Falchook; Hendrik-Tobias Arkenau; Michael Millward; Michael P Brown; Anna Pavlick; Michael A Davies; Bo Ma; Robert Gagnon; Martin Curtis; Peter F Lebowitz; Richard Kefford; Georgina V Long
Journal:  Clin Cancer Res       Date:  2013-07-05       Impact factor: 12.531

6.  Loss of PTEN in high grade advanced stage triple negative breast ductal cancers in African American women.

Authors:  Farhan Khan; Ashwini Esnakula; Luisel J Ricks-Santi; Rabia Zafar; Yasmine Kanaan; Tammey Naab
Journal:  Pathol Res Pract       Date:  2018-03-27       Impact factor: 3.250

7.  Primary squamous cell carcinoma of the endometrium unrelated to human papilloma virus: a molecular study.

Authors:  Giovanna Giordano; Silvia Pizzi; Cinzia Azzoni; Lorena Bottarelli; Tiziana D'Adda
Journal:  Pathol Oncol Res       Date:  2013-02-21       Impact factor: 3.201

Review 8.  Role of the clinical pathology laboratory in the evaluation of endometrial carcinomas for Lynch syndrome.

Authors:  Bojana Djordjevic; Russell R Broaddus
Journal:  Semin Diagn Pathol       Date:  2014-04-02       Impact factor: 3.464

9.  PTEN immunohistochemical expression is suppressed in G1 endometrioid adenocarcinoma of the uterine corpus.

Authors:  F Kimura; J Watanabe; H Hata; T Fujisawa; Y Kamata; Y Nishimura; T Jobo; H Kuramoto
Journal:  J Cancer Res Clin Oncol       Date:  2003-12-20       Impact factor: 4.553

10.  The Synergistic Effect of Conditional Pten Loss and Oncogenic K-ras Mutation on Endometrial Cancer Development Occurs via Decreased Progesterone Receptor Action.

Authors:  Tae Hoon Kim; Jinrong Wang; Kevin Y Lee; Heather L Franco; Russell R Broaddus; John P Lydon; Jae-Wook Jeong; Francesco J Demayo
Journal:  J Oncol       Date:  2009-10-27       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.